Azetidinone-retinoid hybrids: synthesis and differentiative effects

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Epigenetics

Background:

• Systematic investigation of novel beta-lactam compounds.
• Azetidinone 1 is a known selective HDAC8 inhibitor.
• Beta-lactams 2E and 2Z are novel hybrid retinoid-azetidinone structures.

Purpose of the Study:

• To synthesize and characterize new beta-lactam compounds.
• To evaluate the biological activities of beta-lactams 1, 2E, and 2Z.
• To determine the effects of these compounds on neuroblastoma cell proliferation and differentiation.

Main Methods:

• De novo synthesis and full characterization of beta-lactams 2E and 2Z.
• Cellular assays using neuroblastoma cell line SH-SY5Y.
• Evaluation of cell proliferation and differentiation induction.

Main Results:

• Azetidinone 1, 2E, and 2Z moderately decreased SH-SY5Y cell proliferation.
• Beta-lactams 2E and 2Z induced early-stage differentiation in SH-SY5Y cells.
• The tested beta-lactams exhibit biological activity relevant to epigenetic regulation.

Conclusions:

• Designed beta-lactam compounds can influence neuroblastoma cell behavior.
• Novel beta-lactams demonstrate potential in modulating cell proliferation and differentiation.
• These findings suggest a new role for beta-lactams in epigenetic regulation.